MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-17-2025
Zynex Total Assets 2011-2026 | ZYXI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122 M | 137 M | 116 M | 133 M | 72.2 M | 28.3 M | 16.2 M | 8.93 M | 4.09 M | 3.7 M | 7.11 M | 17.2 M | 25.9 M | 21.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 137 M | 3.7 M | 51 M |
Quarterly Total Assets Zynex
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.3 M | 85.9 M | 106 M | 122 M | 126 M | 122 M | 126 M | 137 M | 151 M | 153 M | 111 M | 116 M | 115 M | - | 132 M | 133 M | 90.7 M | 83.7 M | 70.2 M | 72.2 M | 72.2 M | 72.2 M | 72.2 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 19.3 M | 19.3 M | 19.3 M | 19.3 M | 8.93 M | 8.93 M | 8.93 M | 8.93 M | 4.09 M | 4.09 M | 4.09 M | 4.09 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 7.11 M | 7.11 M | 7.11 M | 7.11 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 153 M | 3.7 M | 49.3 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.03 | -0.33 % | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.66 | -0.22 % | $ 5.46 K | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.0 | - | $ 16.9 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.13 | -2.67 % | $ 259 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 169.58 | -1.33 % | $ 12.7 B | USA |
 |
AxoGen
AXGN
|
222 M | $ 31.69 | -2.91 % | $ 1.46 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
256 M | $ 4.04 | -2.42 % | $ 855 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.61 | 3.22 % | $ 38 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.63 | -0.77 % | $ 345 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 61.67 | -1.42 % | $ 91.3 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 10.95 | -0.18 % | $ 1.64 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 33.62 | -1.31 % | $ 1.04 B | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.46 | - | $ 130 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 80.66 | -0.6 % | $ 47.2 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.6 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 88.22 | -0.46 % | $ 11.9 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.84 | -3.16 % | $ 1.12 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.15 | -1.66 % | $ 705 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 53.29 | -1.54 % | $ 1.57 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.28 | -0.4 % | $ 2.96 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.79 | -0.94 % | $ 370 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.87 | -0.34 % | $ 70.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 85.5 | -0.92 % | $ 110 B | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.69 | -1.77 % | $ 28.9 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 23.61 | - | $ 200 M | USA |